Parties & Recitals
Identify each party’s legal name and status; include background facts and purpose to contextualize the license, such as definitions of the IP and reason for equity consideration.
An equity-based exclusive license aligns incentives between licensor and licensee, can reduce upfront cash requirements, and helps startups obtain technology access while preserving long-term upside. It also clarifies exclusivity scope and protects the licensor’s retained rights and future commercialization opportunities.
Legal counsel, corporate finance teams, and securities advisors should be engaged early to manage equity issuance, securities law compliance, and tax consequences.
Founder or company that owns the IP and conveys exclusive rights. The licensor’s counsel prepares or reviews grant language, retention of residual rights, and IP prosecution obligations to avoid unintended assignment of core ownership.
Entity or investor receiving the exclusive license and equity. The licensee must document consideration, vesting, performance milestones, and compliance with securities law, and typically requires board or authorized officer signature authority.
Identify each party’s legal name and status; include background facts and purpose to contextualize the license, such as definitions of the IP and reason for equity consideration.
Specify exclusive territory, field of use, sublicensing rights, and whether exclusivity is absolute or limited by performance milestones or progress requirements.
Describe form (shares, options, warrants), number or percentage, valuation approach, vesting schedule, and issuance mechanics including share class and restrictions.
Define initial term, renewal mechanics, termination for cause or convenience, and post-termination license carve-outs or wind-down rights.
IP ownership, non-infringement, authority to grant rights, and accuracy of corporate standing; include survival periods for key reps.
Allocation of infringement risk, liability caps, injunctive relief for breach of exclusivity, and dispute resolution provisions such as governing law and arbitration.
| Field | Configuration |
|---|---|
| Authentication Type | Email link + optional SMS code for added verification |
| Signature Order | Sequential signing when equity issuance requires board approval |
| Conditional Fields | Show equity issuance fields only after approvals complete |
| Storage Location | Secure cloud storage with audit trail and version control |
Ensure the chosen platform preserves tamper-evident copies, supports audit trails and, when required, offers a Business Associate Agreement for HIPAA-covered situations.
| Criteria | Exclusive | Non-Exclusive |
|---|---|---|
| Transfer of Rights | no transfer | limited rights |
| Equity Component | often yes | rarely |
| Assignability | restricted | often unrestricted |
| Primary Use | strategic partnership | broad licensing |
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies | Varies | Varies | Varies |
| Bulk Send | Yes | Yes | Yes | Yes | Yes |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
Enter as MM/DD/YYYY; this starts vesting and performance obligations
Record issuance date on cap table and share ledger promptly
Track cliff and periodic vesting dates for auditability
Comply with notice provisions set in contract to avoid wrongful termination
Preserve records per IRS and HIPAA timeframes where applicable
Finalize exclusivity, equity, and performance terms between parties
Obtain board, investor, or third-party approvals required for issuance
All parties sign; complete notarization or RON if required
Issue shares, update cap table, and store executed agreement securely
A university spinout licenses experimental software to a startup in exchange for 5% equity and milestone-based payments.
A small medtech company grants exclusive rights to a distributor for a regional market in exchange for 2% equity and sales-based royalties.